In this study, we engineered homogeneous TSC2-deficient LAM patient-derived cells that co-express NIS and GFP and studied their pattern of proliferation and dissemination in vivo, and their response to hormones and drugs. The gene discussed is SLC5A5; the disease is lymphangioleiomyomatosis.